No Data
Healios' ONE-BRIDGE Trial Data on ARDS Published in Regenerative Therapy
Healios K.K Submits Approval Application for ARDS Treatment in Japan
Helios, Synspective.
Nomura <4593> Helios BUY maintained <290A> Synspecitve BUY maintained *The ratings for the above companies are based on our confirmation as of December 3rd.
Jefferies Adjusts Healios' Price Target to 390 Yen From 320 Yen, Keeps at Buy
SBSHD, Kirin HD, etc. (additional) Rating.
Upgrades - Bullish Code Stock Name Securities Company Previous After -------------------------------------------------------------- <4971> Meck Morgan Stanley "Equal Weight" "Overweight" <5831> Shizuoka Financial Group Morgan Stanley "Equal Weight" "Overweight" <5838> Rakuten Bank Morgan Stanley "Equal Weight" "Overweight" Downgrades - Bearish Code Stock Name Securities Company Previous After --------
Rating information (Target Price change - Part 1) = Syns, Tokio Marine, etc.
◎ Nomura Securities (three-tiered: Buy > neutral > Reduce) Syns<290A.T>―― "Buy" → "Buy", 740 yen → 818 yen Helios<4593.T>―― "Buy" → "Buy", 300 yen → 340 yen Nippon Steel<5401.T>―― "Buy" → "Buy", 4000 yen → 3900 yen SkyPerfecTV<9412.T>―― "Buy" → "Buy", 1210 yen → 1330 yen Cell Source<4880.T>―― "neutral" → "new.